低氧条件下奥巴克拉联合吉西他滨对乳腺癌细胞的作用

doi:10.12047/j.cjap.5955.2020.059

摘要/Abstract

摘要： 目的: 研究在低氧条件下,奥巴克拉(OBX)联合吉西他滨(GEM)对乳腺癌细胞MCF-7、BT-20的细胞活性、迁移、侵袭及凋亡的影响。方法: 选取乳腺癌细胞MCF-7与BT-20细胞,分组为正常氧组,低氧组,GEM组,OBX+GEM组。正常氧组:37℃,5% CO₂培养箱培养24 h与48 h;低氧组:37℃,1%O₂,5% CO₂ ,94% N₂条件下培养24 h与48 h; GEM组:37℃,1%O₂,5% CO₂ , 94% N₂,加入终浓度为10 μmol/L的GEM培养24 h与48 h;OBX+ GEM组:7℃,1%O₂,5% CO₂ ,94% N₂,加入终浓度为10 μmol/L的GEM与终浓度为50 nmol/L的OBX培养24 h与48 h。利用Western blot检测正常氧及低氧条件下MCF-7与BT-20细胞中低氧诱导因子(HIF-1α)的表达;利用CCK-8实验检测各组中MCF-7与BT-20细胞活性,每组设置15个复孔;利用划痕实验检测各组MCF-7与BT-20细胞迁移能力,每组设置6个复孔;利用Western blot检测各组MCF-7细胞中vimentin、E-Cadherin及p53蛋白的表达。结果: HIF-1α在低氧条件下培养的细胞中的表达远远高于其在正常氧条件下培养的细胞中的表达(P＜0.05),说明低氧条件成功;与低氧组相比较,GEM可降低MCF-7与BT-20细胞迁移能力和细胞活性(P＜0.05),减少细胞中vimentin的表达(P＜0.01),促进E-Cadherin和p53的表达(P＜0.01);与GEM组相比较,OBX联合GEM组可明显降低细胞活性和MCF-7与BT-20细胞的迁移能力(P＜0.01),显著降低细胞中vimentin的表达(P＜0.01),显著升高E-Cadherin和p53的表达(P＜0.01)。结论:在低氧条件下,OBX联合小剂量GEM可显著抑制乳腺癌细胞的生长、迁移、侵袭,增强GEM对乳腺癌细胞的促凋亡作用,具体机制尚需要进一步研究。

关键词: 奥巴克拉, 吉西他滨, 低氧, 乳腺癌, 表型

Abstract: Objective: To explore the effects of obatoclax(OBX) combined with gemcitabine(GEM) on breast cancer cells MCF-7 and BT-20 cell activity, migration, invasion and apoptosis under hypoxia condition.Methods: Breast cancer cells MCF-7 and BT-20 were divided into normal group, hypoxia group, GEM group, OBX+GEM group. Normal group: Cells were cultured at 37℃, 5% CO₂ for 24 h and 48 h; Hypoxia group: Cells were cultured at 37℃, 1% O₂, 5% CO₂, 94% N₂ for 24 h and 48 h; GEM group: Cells were cultured at 37℃, 1% O₂, 5% CO₂, 94% N₂, adding 10 μmol/L GEM for 24 h and 48 h; OBX + GEM group: Cells were cultured at 37℃, 1% O₂, 5% CO₂, 94% N₂, adding 10 μmol/L GEM and 50 nmol/L OBX for 24 h and 48 h. Western blot method was used to detect the expressions of HIF-1α in MCF-7 and BT-20 cells under normal oxygen and hypoxia condition. CCK-8 method was used to detect cancer cell activity, each group was provided with 15 compound holes. Scratch experiment was used to detect cells migration ability, each group was provided with 6 compound holes. Western blot method was used to detect the expressions of vimentin, E-Cadherin and p53 protein in cells of each group. Results: Under hypoxia condition, the expression of HIF-1α in MCF-7 and BT-20 cells was much higher than that under normal oxygen(P＜0.05). Compared with hypoxia group, GEM could reduce MCF-7 and BT-20 cells migration ability(P＜0.01)and cell activity(P＜0.05), while decrease the expression of vimentin protein(P＜0.01)and promote the expressions of E-Cadherin (P＜0.01)and p53 protein(P＜0.01) in tumor cells under hypoxia condition. In OBX combined with GEM group, the cell activity and the migration ability of MCF-7 and BT-20 were reduced significantly(P＜0.01). The expression of vimentin in cells was further reduced(P＜0.01). The expressions of E-Cadherin(P＜0.01)and p53(P＜0.01) protein were increased significantly compared with GEM group. Conclusion: Under hypoxia condition, OBX combined with a low-dose of GEM can significantly inhibit the growth, migration and invasion of breast cancer cells, and enhance the pro-apoptotic effect of GEM, but the specific mechanism needs further study.

Key words: obatoclax, gemcitabine, hypoxia, breast cancer, phenotype

中图分类号:

R737.9

宋海岩, 张毅敏, 连辉, 周立. 低氧条件下奥巴克拉联合吉西他滨对乳腺癌细胞的作用[J]. 中国应用生理学杂志, 2020, 36(3): 268-272.

SONG Hai-yan, ZHANG Yi-min, LIAN Hui, ZHOU Li. Effects of obatoclax combined with gemcitabine on breast cancer cells under hypoxia condition[J]. CJAP, 2020, 36(3): 268-272.

参考文献

[1] Cosse JP, Michiels C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression[J]. Anticancer Agents Med Chem, 2008, 8(7): 790-797.
[2] Vaupel P1, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia[J]. Med Oncol, 2001, 18(4): 243-259.
[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[4] He K, Wang X , Guan X, et al. Vinorelbine plus gemcitabine or cisplatin as first-line treatment of HER2-negative advanced breast cancer[J]. Anticancer Res, 2017, 37(10): 5647-5653.
[5] 崔文秀, 郝吉庆.吉西他滨不同给药方式联合顺铂治疗晚期乳腺癌的临床疗效及安全性[J]. 现代肿瘤医学, 2018, 26(13): 2048-2050.
[6] Shore GC, Viallet J. Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer[J]. Hematology Am Soc Hematol Educ Program, 2005: 226-230.
[7] 王红磊, 肖奕, 武力, 等. miR-449a对人乳腺癌细胞MCF-7增殖及迁移能力的影响[J].中国应用生理学杂志, 2017, 33(6): 508-513.
[8] 李玉军, 李力, 梁朝群, 等.低氧诱导因子-1α表达与胰腺癌增殖和凋亡的关系[J]. 青岛大学医学院学报, 2004, 40(1): 11-14.
[9] Schwab LP, Peacock DL, Majumdar D, et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer[J]. Breast Cancer Res, 2012, 14(1): 1-25.
[10]Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor andtransforming growth factor-beta-dependent mechanisms[J]. Liver Int, 2010, 30(5): 669-682.
[11]Ito K, Park SH, Nayak A, et al. PTK6 inhibition suppresses metastases of triple-negative breast cancer via SNAIL-dependent E-Cadherin regulation[J]. Cancer Res, 2016, 76(15): 4406-4417.
[12]Lazarova DL, Bordonaro M. Vimentin, colon cancer progression and resistance to butyrate and other HDACis[J]. J Cell Mol Med, 2016, 20(6): 989-993.
[13]Klymenko T, Brandenburg M, Morrow C, et al. The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxiainduced drug resistance in neuroblastoma cells[J]. Mol Cancer Ther, 2011, 10(12): 2373-2383.
[14]Harrison LR, Micha D, Brandenburg M, et al. Hypoxic human cancer cells are sensitized to BH-3 mimetic-induced apoptosis via downregulation of the Bcl-2 protein Mcl-1[J]. J Clin Invest, 2011, 121(3): 1075-1087.
[15]Gariboldi MB, Taiana E, Bonzi MC. The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil[J]. Cancer Lett, 2015, 364(2): 156-164.